Other non-invasive markers of liver fibrosis.
An intensive research effort in the field of non-invasive evaluation of liver fibrosis has recently permitted the description and validation of several serum markers of fibrosis, mainly in chronic hepatitis C patients. In addition to the commonly used tests such as FibroTest or FibroMeters, other either indirect (aspartate aminotransferase, prothrombin time, platelets) or direct (PIIINP, hyaluronic acid, metalloproteinases) markers, usually used in combination, have been evaluated. Simple scores such as APRI or FIB-4 have also been widely studied and have revealed interesting, albeit non-comprehensive, data on liver fibrosis, especially in terms of significant, extensive fibrosis or cirrhosis. These simple scores may be proposed as a first-line investigation, bearing in mind their limitations and comparing them with more accurate methods for evaluating liver fibrosis if necessary. Other scores, including direct serum markers, which can be difficult to assess, have given disappointing results that, in general, were either similar to, or only slightly better than, the results of the simpler tests. Further studies are needed to identify new markers that are more accurate and, above all, able to predict the outcome of liver fibrosis.
Leroy
V
V
Clinique d'Hépato-gastroentérologie, pôle DIGI-DUNE, CHU de Grenoble; INSERM/UJ FU823, IAPC, IAB, Grenoble. VLeroy@chu-grenoble.fr
D015415:Biomarkers / Q000097:blood; D006403:Hematologic Tests; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood* / Q000175:diagnosis*
D015415:Biomarkers